Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Friday, March 8, 2019

Pain Therapeutics Announces Feedback from Recent Meeting With FDA on Remoxy

›
      In continuation of my update on  Remoxy ER (oxycodone) Pain Therapeutics, Inc. (Nasdaq: PTIE), a clinical-stage drug developmen...
Thursday, March 7, 2019

FDA Grants Priority Review for Daiichi Sankyo’s New Drug Application for CSF1R Inhibitor Pexidartinib for Treatment of Patients with TGCT, a Rare, Debilitating Tumor

›
   Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the U.S. Food and Drug Administration (FDA) has accepted a...
Wednesday, March 6, 2019

Zogenix Submits New Drug Application to U.S. Food & Drug Administration for Fintepla for the Treatment of Dravet Syndrome

›
      Zogenix, Inc. (NASDAQ:ZGNX), a global pharmaceutical company developing rare disease therapies,  announced it has completed it...
Tuesday, March 5, 2019

Latest anti-retroviral drug therapies offer powerful solution for HIV infection-associated frailty

›
In continuation of my update on  anti-retroviral drug   reatment of the HIV/AIDS epidemic has seen remarkable advancements with the ad...

FDA Advisory Committee Recommends Approval of Spravato (esketamine) Nasal Spray for Adults with Treatment-Resistant Depression

›
     The Janssen Pharmaceutical Companies of Johnson & Johnson  announced that the U.S. Food and Drug Administration (FDA) Psychop...
Saturday, March 2, 2019

FDA Approves Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP), First Generic of Advair Diskus

›
In continuation of my updates on  fluticasone propionate & salmeterol                Mylan N.V. (NASDAQ: MYL)  announced the U.S....
Friday, March 1, 2019

FDA Approves Egaten (triclabendazole) for the Treatment of Fascioliasis, a Neglected Tropical Disease

›
Novartis announced that the US Food and Drug Administration (FDA) has approved Egaten (triclabendazole) for the treatment of fasciolias...
Thursday, February 28, 2019

PTSD Drug, Prazosin, May Do More Harm Than Good

›
I n continuation of my update on  prazosin A drug used to treat post-traumatic stress disorder ( PTSD ) may actually be harm...
Wednesday, February 27, 2019

Animal Study Suggests Ritalin Won't Harm the Heart

›
     In continuation of my update on Ritalin  Ritalin , a widely used stimulant drug to treat attention-deficit/hyperactivity d...
Tuesday, February 26, 2019

Rituximab (Rituxan) May Delay MS Disability

›
In continuation of my update on rituximab An immune system drug may help prevent or slow complications in a type of multiple sclerosis k...
Saturday, February 23, 2019

Psoriasis Meds Might Help Fight Heart Trouble, Too

›
  Could the inflammation that drives   psoriasis   and other immune-linked illnesses be a major player in heart disease? In a new stud...
Friday, February 22, 2019

New class of sleeping pill preserves ability to wake in response to danger signals

›
https://chem.nlm.nih.gov/chemidplus/rn/1088991-95-0 In a trial of one of the main class of prescription sleeping pills, half the...
‹
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.